An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis

NCT06764693 · clinicaltrials.gov ↗
RECRUITING
Status
1200
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AbbVie